R&D investor study finds benchmarking, not multi-dimensional portfolios, a key factor in market value

A study of corporate R&D investors has found that while some companies place significant value on IP portfolios that include a combination of rights, markets grant higher premiums to those that are more innovative than their competitors.

Get unlimited access to all WTR content